memo, page-5

Quarterly Report due in around 10days time, an opportunity for an update on Medivet progress, and hopefully expand (sales) on the investment made in the sales team and marketing.

Thought I'd have a crack at estimating the results.

Using Rev & COGS growth rates provided in the FY report, and the geographical revenue breakdown I'm expecting 4.18m Sept14Q revenue, an increase of 9.3% on Sept14 of $3.83m.

I'm expecting a small positive Sep15Q earnings (<100k), driven by a reduction in receivables & Inventory levels.

Also, I'm guessing we will be seeing some of Bruce Hancox's (of Brierleys fame & Lang Walker's chum) M&A abilities in the next 3-6mths, following a resolution on the Medivet holding, some cash should be 'freed' for other activities. He's had 12mths on the board now and I'm guessing there are plans to better utilise his expertise.

DYOR, IMO etc...